RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study-Reference-Cited by-同舟云学术

RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

Published:2007-04 Issue:9571 Volume:369 Page:1431-1439
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mochizuki Seibu,Dahlöf Björn,Shimizu Mitsuyuki,Ikewaki Katsunori,Yoshikawa Makoto,Taniguchi Ikuo,Ohta Makoto,Yamada Taku,Ogawa Kazuhiko,Kanae Kiyoshi,Kawai Makoto,Seki Shingo,Okazaki Fumiko,Taniguchi Masayuki,Yoshida Satoru,Tajima Naoko

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic;Bonow;Circulation,2002

2. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study;Kubo;Stroke,2003

3. The cellular and molecular response of cardiac myocytes to mechanical stress;Sadoshima;Annu Rev Physiol,1997

4. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease;Brunner;Am J Cardiol,2001

5. Molecular and cellular mechanisms of angiotensin II mediated cardiovascular and renal diseases;Kim;Pharmacol Rev,2000

Cited by 296 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of angiotensin II type 1 receptor pathway in cerebral ischemia‒reperfusion injury: Implications for the neuroprotective effect of ARBs;Neuroprotection;2024-06

2. Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review;Clinical and Translational Science;2024-05

3. Sidesplitting using network meta-regression;Japanese Journal of Biometrics;2024

4. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease;The Journal of Thoracic and Cardiovascular Surgery;2023-11

5. Highlights and Perioperative Implications from the 2022 American College of Cardiology and American Heart Association Guidelines for Diagnosis and Management of Aortic Disease;Journal of Cardiothoracic and Vascular Anesthesia;2023-10